Interleukin 13 and its role in gut defence and inflammation.
about
Epidermal Growth Factor and Intestinal Barrier FunctionCurrent stage in inflammatory bowel disease: What is next?Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases.Low serum interleukin-13 levels correlate with poorer prognoses for colorectal cancer patients.Genetic deletion of the bacterial sensor NOD2 improves murine Crohn's disease-like ileitis independent of functional dysbiosis.What does irritable bowel syndrome share with non-alcoholic fatty liver disease?Semaphorin 3A controls allergic and inflammatory responses in experimental allergic conjunctivitis.Wrestlers' immune cells produce higher interleukin-6 and lower interleukin-12 and interleukin-13 in response to in vitro mitogen activationOleanolic acid controls allergic and inflammatory responses in experimental allergic conjunctivitisCyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis.Early Persistent Blood Eosinophilia in Necrotizing Enterocolitis Is a Predictor of Late Complications.Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis.Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac diseaseUlcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valleyCytokine patterns differ seasonally between women with and without uterine leiomyomataThe immunological landscape in necrotising enterocolitisIL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells.Effect of predatory bacteria on the gut bacterial microbiota in rats.Tissue dendritic cells as portals for HIV entry.Emerging drugs for eosinophilic esophagitis.Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.Th9 cells in inflammatory bowel diseases.Interleukin-13 interferes with activation-induced t-cell apoptosis by repressing p53 expression.Immune balance: the development of the idea and its applications.Novel treatment options for ulcerative colitis.Serum IL-17 and IL-6 increased accompany with TGF-β and IL-13 respectively in ulcerative colitis patientsSerum cytokine pattern in young children with screening detected coeliac disease.Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study.Antiobesity and Anti-Inflammatory Effects of Orally Administered Bonito Extracts on Mice Fed a High-Fat Diet.Engineering the expression of an anti-interleukin-13 antibody through rational design and mutagenesis.Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice.MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1.Due diligence in the characterization of matrix effects in a total IL-13 Singulex™ method.High physical activity in young children suggests positive effects by altering autoantigen-induced immune activity.Targeting IL-13 as a Host-Directed Therapy Against Ulcerative Colitis
P2860
Q26741547-251A8065-59BF-409C-BDF0-E25287E90889Q26777429-AAFF994F-F20B-432F-9D73-D18874191A7BQ30902172-586DC158-E46F-4E56-9D24-A0EEDF51774FQ33636910-B86D4083-3482-42D5-B54D-B65EC2DBEA99Q33694206-8ABE5B4B-DD74-4073-8CC7-FD245181CD2DQ34983471-031C4144-1512-4A20-9D37-BCEEBA6F2E96Q35075328-C5A57A6D-839B-41DE-AECA-A038EDFEEE2AQ35083589-2222BF33-D810-42B8-B4FD-276082BB8915Q35139177-C843D238-6F7D-49A5-9958-BA34990AA7ABQ35231496-CF6C0456-F1FA-4E02-8B5B-78AA0200F8A3Q35967497-86A4C5BE-1D22-4E30-8E95-6583F2FCFAEFQ36010505-EE7A8561-BBD1-43AA-B919-7C56CDE7CC00Q36830918-59061247-7A1D-4B08-A759-6512CFDB1DFAQ37072627-F3BE9295-024C-41D8-9002-EC2C6559EA35Q37100122-213E0FC1-6A97-4F13-8D85-5AAF4207E763Q37210802-46E14193-1192-4BC3-835C-4635A755AA22Q37641580-B713778D-D13A-45A8-8136-3C12C913CE98Q37681737-A603815B-1527-466B-B7DD-AAC952ECB989Q38125962-3ECC829D-F19D-4FB1-969B-872D62AFE3B9Q38128368-C4630721-D31F-449A-BE59-CA4FE3EEECE7Q38805575-1ED4AB14-5D7F-43C9-B26B-E82943F63410Q39006003-580D01EC-1859-42D6-B610-2706CF71C35AQ41188761-130381F8-62AC-4020-9A3F-BCB5BFEC0484Q41553378-58EBB578-77C5-4B54-BCF3-2FA07A97DBDDQ41949151-A3F15069-3318-4136-A605-256F3A6F57ACQ41985685-2EF5DE80-052B-4EA4-81D2-B01E483CF36DQ42117584-FB29C6AB-1279-45B4-AE45-3D9F7F60CA9FQ44799322-B305202D-F333-41C6-AD62-D206389394E3Q47136403-8463E2D0-CDBD-4578-A6F6-E33309F1346FQ47988148-AA22B3E7-E592-40CD-BCC7-FABB517917D8Q49959033-C47BABF6-5579-4860-A128-91596B16F245Q50042190-2FF6502F-F65C-4669-A4B5-CCD91993DB13Q50684767-0F9ACD6F-E24F-41DB-B2A7-FACF468B44F9Q52950124-D32DD532-E954-4DFF-BF85-08134C272114Q59128301-F8391477-5B9F-4D10-AA20-42618EF6A3AF
P2860
Interleukin 13 and its role in gut defence and inflammation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interleukin 13 and its role in gut defence and inflammation.
@en
type
label
Interleukin 13 and its role in gut defence and inflammation.
@en
prefLabel
Interleukin 13 and its role in gut defence and inflammation.
@en
P1433
P1476
Interleukin 13 and its role in gut defence and inflammation.
@en
P2093
Peter Mannon
Walter Reinisch
P304
P356
10.1136/GUTJNL-2012-303461
P407
P577
2012-09-01T00:00:00Z